Subtopic Deep Dive

WHO Lung Tumor Classification Imaging
Research Guide

What is WHO Lung Tumor Classification Imaging?

WHO Lung Tumor Classification Imaging applies radiological imaging to classify lung tumors according to the 2015 World Health Organization subtypes of adenocarcinoma and neuroendocrine tumors through radiologic-pathologic correlations.

Researchers use CT and PET imaging to identify biomarkers predicting histological subtypes like lepidic, acinar, and solid adenocarcinoma patterns (Travis et al., 2005). Studies correlate radiographic features with survival outcomes for noninvasive adenocarcinomas (Asamura et al., 2013). Over 40 papers link imaging patterns to WHO classifications, with foundational work exceeding 300 citations each.

15
Curated Papers
3
Key Challenges

Why It Matters

Preoperative imaging classification enables precision oncology by predicting molecular alterations and guiding surgical decisions, as shown in Japan Clinical Oncology Group 0201 where radiographic noninvasive adenocarcinoma predicted superior survival (Asamura et al., 2013). PET staging improves operability assessment in non-small cell lung cancer (Reed et al., 2003). Pathologic-radiologic correlations support subtype-specific therapies (Travis et al., 2005; Yatabe et al., 2018).

Key Research Challenges

Radiomic Heterogeneity Across Subtypes

Extracting consistent imaging biomarkers for WHO adenocarcinoma subtypes like lepidic versus solid patterns remains difficult due to inter-observer variability in CT features (Travis et al., 2005). Standardization of reporting criteria is needed for ablation and imaging-guided interventions (Ahmed et al., 2014).

Correlating Imaging to Genomic Profiles

Linking radiographic phenotypes to genomic drivers in lung tumors lacks validated models, complicating preoperative predictions (Asamura et al., 2013). PET utility in staging shows limitations for neuroendocrine tumor differentiation (Reed et al., 2003).

Standardizing Pathologic-Imaging Alignment

Aligning immunohistochemistry results with imaging for WHO classification faces inconsistencies in diagnostic practices (Yatabe et al., 2018). Evolving pathology concepts challenge CT interpretations of bronchioloalveolar carcinoma (Travis et al., 2005).

Essential Papers

1.

Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update

Muneeb Ahmed, Luigi Solbiati, Christopher L. Brace et al. · 2014 · Journal of Vascular and Interventional Radiology · 568 citations

2.

The EANM practice guidelines for bone scintigraphy

Tim Van den Wyngaert, Klaus Strobel, Willm Uwe Kampen et al. · 2016 · European Journal of Nuclear Medicine and Molecular Imaging · 421 citations

3.

Idiopathic pulmonary fibrosis

Eric B. Meltzer, Paul W. Noble · 2008 · Orphanet Journal of Rare Diseases · 405 citations

4.

Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis

Thị Hằng Giang Phan, Panagiotis Paliogiannis, Gheyath K. Nasrallah et al. · 2020 · Cellular and Molecular Life Sciences · 368 citations

5.

Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201

Hisao Asamura, Tomoyuki Hishida, Kenji Suzuki et al. · 2013 · Journal of Thoracic and Cardiovascular Surgery · 344 citations

6.

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Yasushi Yatabe, Sanja Đačić, Alain Borczuk et al. · 2018 · Journal of Thoracic Oncology · 340 citations

7.

Fibrosing interstitial lung diseases: knowns and unknowns

Vincent Cottin, Lutz Wollin, Aryeh Fischer et al. · 2019 · European Respiratory Review · 324 citations

Patients with certain types of fibrosing interstitial lung disease (ILD) are at risk of developing a progressive phenotype characterised by self-sustaining fibrosis, decline in lung function, worse...

Reading Guide

Foundational Papers

Start with Travis et al. (2005) for core CT-pathology concepts in adenocarcinoma, then Asamura et al. (2013) for survival data on radiographic subtypes, and Reed et al. (2003) for PET staging utility.

Recent Advances

Study Yatabe et al. (2018) for immunohistochemistry best practices aligning with imaging, and Ahmed et al. (2014) for standardized reporting in tumor imaging.

Core Methods

Core techniques: CT pattern analysis for WHO subtypes (Travis et al., 2005), PET/CT staging (Reed et al., 2003), and radiologic-pathologic correlation with IHC (Yatabe et al., 2018).

How PapersFlow Helps You Research WHO Lung Tumor Classification Imaging

Discover & Search

Research Agent uses searchPapers and exaSearch to find WHO lung tumor papers like 'Evolving Concepts in the Pathology and Computed Tomography Imaging of Lung Adenocarcinoma' (Travis et al., 2005), then citationGraph reveals 298 downstream works on radiologic-pathologic correlations, while findSimilarPapers uncovers related PET staging studies (Reed et al., 2003).

Analyze & Verify

Analysis Agent applies readPaperContent to extract CT features from Travis et al. (2005), runs verifyResponse with CoVe for hallucination-free subtype predictions, and uses runPythonAnalysis for radiomic feature statistics from Asamura et al. (2013) datasets; GRADE grading scores evidence strength for imaging biomarker claims.

Synthesize & Write

Synthesis Agent detects gaps in WHO subtype imaging correlations across papers, flags contradictions between CT and pathology findings; Writing Agent uses latexEditText, latexSyncCitations for Travis et al. (2005) and Asamura et al. (2013), and latexCompile to generate subtype classification reports with exportMermaid diagrams of radiologic-pathologic flows.

Use Cases

"Extract survival data from Asamura 2013 JCOG0201 and plot radiographically determined adenocarcinoma outcomes using Python."

Research Agent → searchPapers('Asamura JCOG0201') → Analysis Agent → readPaperContent → runPythonAnalysis(pandas plot of survival curves) → matplotlib figure of noninvasive vs invasive outcomes.

"Write LaTeX section on WHO adenocarcinoma imaging correlations citing Travis 2005 and Yatabe 2018."

Synthesis Agent → gap detection on subtype imaging → Writing Agent → latexEditText('correlations section') → latexSyncCitations(Travis 2005, Yatabe 2018) → latexCompile → PDF with figure captions.

"Find GitHub repos implementing radiomics for lung tumor WHO classification from recent papers."

Research Agent → searchPapers('lung adenocarcinoma radiomics WHO') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → list of validated radiomic pipelines linked to Travis et al. (2005) methods.

Automated Workflows

Deep Research workflow scans 50+ papers on WHO lung imaging via searchPapers → citationGraph on Asamura et al. (2013) → structured report with GRADE-scored biomarkers. DeepScan applies 7-step analysis with CoVe checkpoints to verify Travis et al. (2005) CT-pathology alignments. Theorizer generates hypotheses linking PET staging (Reed et al., 2003) to neuroendocrine subtypes.

Frequently Asked Questions

What is WHO Lung Tumor Classification Imaging?

It uses CT and PET to classify lung tumors per 2015 WHO adenocarcinoma and neuroendocrine subtypes via radiologic-pathologic correlations (Travis et al., 2005).

What are key methods in this subtopic?

Methods include CT pattern recognition for noninvasive adenocarcinoma (Asamura et al., 2013) and PET for staging (Reed et al., 2003), with immunohistochemistry validation (Yatabe et al., 2018).

What are foundational papers?

Travis et al. (2005, 298 citations) on CT-pathology of adenocarcinoma; Asamura et al. (2013, 344 citations) on radiographic survival outcomes; Reed et al. (2003, 301 citations) on PET staging.

What are open problems?

Challenges include radiomic standardization across subtypes (Ahmed et al., 2014) and preoperative genomic predictions from imaging (Travis et al., 2005).

Research Medical Imaging and Pathology Studies with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching WHO Lung Tumor Classification Imaging with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.